4//SEC Filing
Kasahara Noriyuki 4
Accession 0001610717-23-000067
CIK 0001650648other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 7:31 PM ET
Size
5.7 KB
Accession
0001610717-23-000067
Insider Transaction Report
Form 4
Kasahara Noriyuki
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-23+22,500→ 22,500 totalExercise: $17.98Exp: 2033-05-22→ Common Stock (22,500 underlying)
Footnotes (2)
- [F1]Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- [F2]The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2024 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2026. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001943840
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 7:31 PM ET
- Size
- 5.7 KB